Thus, targeting the survivin protein can result in the activation of apoptosis-related protein expression in intrinsic and extrinsic pathways, phosphatidylinositol 3-kinase (P13K)/Akt pathway, which result in enhanced apoptosis in various cancer cells including prostate, myeloid leukemia, lung, and breast cancer [22]. Here, BIRC5 is linked to cancer.